Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ezetimibe/simvastatin versus atorvastatin in elderly patients with hypercholesterolemia at CHD risk
2007-004448-60Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ezetimibe and atorvastatin in hypercholesterolemia (5 arms), sponsored by Merck & Co. Primary endpoint: Mean percent change from baseline in LDL-C after 12 weeks. Started Aug 2007; status: completed.
02
Drugs
ezetimibeatorvastatin
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on 2007-004448-60.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004448-60.